Dr. Kwatra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 N Caroline St Ste 8065
Baltimore, MD 21287Phone+1 410-955-5933Fax+1 410-502-2309
Education & Training
- Johns Hopkins UniversityResidency, Dermatology, 2012 - 2015
- Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2012
- Duke UniversityBS
Certifications & Licensure
- MD State Medical License 2017 - 2026
- IL State Medical License 2012 - 2013
- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Elevated C-reactive protein levels and cardiovascular risk in prurigo nodularis patients with sleep disturbance: a multi-center cohort study.Emily Z Ma, Varsha Parthasarathy, Kevin K Lee, Shahin Shahsavari, Davies Gage
Archives of Dermatological Research. 2024-12-07 - Risk factors and temporal associations of progression of the atopic march in children with early-onset atopic dermatitis.Una E Choi, Junwen Deng, Varsha Parthasarathy, Viviane Liao, Anjali D'Amiano
Journal of the American Academy of Dermatology. 2024-11-28 - Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.Sonja Ständer, Gil Yosipovitch, Franz J Legat, Adam Reich, Carle Paul
JAMA Dermatology. 2024-11-27
Journal Articles
- Itching at Night: A Review on Reducing Nocturnal Pruritus in ChildrenEmily Boozalis, Bernard A Cohen, Anna L Grossberg, Shawn G Kwatra, Katherine B Puttgen, Pediatric Dermatology
Press Mentions
- New Drug Class for Prurigo Nodularis Moving ForwardOctober 7th, 2024
- Once Considered Rare, an Itchy Dermatologic Skin Disorder Is More Common Than ThoughtAugust 26th, 2019
- Proposing a Stratification Scheme for Chronic Pruritus of Unknown Origin Nomenclature Based on Presence of Eosinophilia: Implications for Therapeutics and Cohort Homogeneity for Clinical TrialsJuly 29th, 2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: